1 / 4

Oncology Drugs Market Size Is Developing Rapidly Worth $436.76 Billion By 2028

The global oncology drugs market size is expected to reach USD 436.76 billion by 2028, according to a new report by Million Insights. It is expected to expand at a CAGR of 12.0% from 2021 to 2028.

MarketInsights
Télécharger la présentation

Oncology Drugs Market Size Is Developing Rapidly Worth $436.76 Billion By 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Oncology Drugs Market Size Is Developing Rapidly Worth $436.76 Billion By 2028 “The global oncology drugs market size is expected to reach USD 436.76 billion by 2028. It is expected to expand at a CAGR of 12.0% from 2021 to 2028. The market is expected to witness growth due to the rising prevalence of cancer, availability of medical resources for detecting and treating cancer patients, increasing pollution levels, and changing lifestyles. The global oncology drugs market size is expected to reach USD 436.76 billion by 2028. It is expected to expand at a CAGR of 12.0% from 2021 to 2028. The market is expected to witness growth due to the rising prevalence of cancer, availability of medical resources for detecting and treating cancer patients, increasing pollution levels, and changing lifestyles. Additionally, the rising per capita income and the increasing purchasing power are other significant factors driving the growth of the market. The prostate segment is expected to register the second-fastest CAGR of 13.5% from 2021 to 2028. Prostate cancer is the second leading cause of cancer-related deaths among men. Obesity and consumption of foods with high calcium levels are some of the major factors leading to prostate cancer. Genetic mutation is also a major factor causing prostate cancer. Growing awareness about the disease is contributing to various treatments and related drugs. Thus, the market is expected to witness increasing revenue from prostate drugs during the forecast period. North America held the largest revenue share of more than 40% in 2020. The U.S. is positively contributing to the growth of the regional market. The presence of well-established pharmaceutical vendors is one of the key factors supporting the growth. North America is one of the promising regions to launch new technology in terms of well healthcare infrastructure and advanced research and development activities that help innovate and produce the most appropriate drugs to cure cancer. Additionally, ease of availability of drugs and reimbursement policies for the patients in the healthcare industry are contributing to revenue generation. Request Sample Copy of This Market Research @ https://www.millioninsights.com/snapshots/oncology-drugs-market-report/request-demo

  2. Oncology Drugs Market Report Highlights • North America held the largest revenue share of more than 40% in 2020. The presence of well-established pharmaceutical vendors is one of the key factors supporting the growth of the regional market • The prostate segment is expected to register the second-fastest CAGR of 13.5% from 2021 to 2028. Growing awareness about prostate cancer is contributing to various treatments and related drugs • The breast segment is likely to expand at the highest CAGR of 13.8% from 2021 to 2028, due to the rising prevalence and awareness regarding breast cancer Oncology Drugs Market Segmentation Million Insights has segmented the global oncology drugs market based on indication and region: • Oncology Drugs Indication Outlook (Revenue, USD Million, 2017 - 2028) • Lung • Breast • Colorectal • Prostate • Stomach • Liver • Others • Oncology Drugs Regional Outlook (Revenue, USD Million, 2017 - 2028) • North America • U.S. • Europe • Germany • France

  3. • U.K. • Asia Pacific • • Central & South America • Brazil Middle East & Africa • South Africa China Japan • • List of Key Players of the Oncology Drugs Market • Merck • Novartis • JOHNSON & JOHNSON • Pfizer • AstraZeneca • Eli Lilly • Hoffmann-La Roche • AbbVie • Sanofi • GSK Browse Full Research Report @ https://www.millioninsights.com/snapshots/oncology-drugs-market-report

  4. Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Million Insights 410 E Santa Clara Street, Unit #1008 San Jose,CA 95113, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Asia Pacific Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 91-8956380892

More Related